ALDH2 Protects Against Ischemic Stroke in Rats by Facilitating 4-HNE Clearance and AQP4 Down-Regulation

Original Paper
  • 32 Downloads

Abstract

Aldehyde dehydrogenase 2 (ALDH2) is a new therapeutic target in the central nervous system. However, the association between ALDH2 and brain edema following ischemic stroke (IS) remains unclear. The present study was investigated to whether active ALDH2 can attenuate brain edema by using a rat model of IS, with the aim of clarifying the underlying mechanisms involved. Rats were administered the ALDH2 agonist Alda-1, vehicle or the ALDH2 inhibitor cyanamide (CYA) 15 min prior to a 1.5 h middle cerebral artery occlusion (MCAO) surgery. The effects of ALDH2 were subsequently investigated 24 h after reperfusion by evaluating neurological function, infarct sizes, brain edema volumes, 4-hydroxy-2-nonenal (4-HNE) levels, and aquaporin 4 (AQP4) protein expression. The results demonstrated that increasing ALDH2 activity significantly improved neurological deficits, reduced infarct sizes, and attenuated brain edema after MCAO. Alda-1 administration led to decreased 4-HNE levels and inhibited AQP4 protein expression in the peri-infarct section of the brain. Whereas, CYA administration increased 4-HNE levels, AQP4 expression, and simultaneously aggravated brain edema following MCAO. In conclusion, increasing ALDH2 activity can improve brain edema, infarct volumes, and reduce neurological impairment in a rat IS model. The therapeutic benefits of ALDH2 are related to 4-HNE clearance and AQP4 down-regulation.

Keywords

ALDH2 Middle cerebral artery occlusion Brain edema Aquaporin 4 4-HNE 

Notes

Acknowledgements

The project is supported by the National Natural Science Foundation of China (No. 81271456).

Compliance with Ethical Standards

Conflict of interest

No competing interests exist.

References

  1. 1.
    Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612–1623.  https://doi.org/10.1016/S0140-6736(08)60694-7 CrossRefPubMedGoogle Scholar
  2. 2.
    Viitanen M, Winblad B, Asplund K (1987) Autopsy-verified causes of death after stroke. Acta Med Scand 222(5):401–408CrossRefPubMedGoogle Scholar
  3. 3.
    Vella J, Zammit C, Di Giovanni G, Muscat R, Valentino M (2015) The central role of aquaporins in the pathophysiology of ischemic stroke. Front Cell Neurosci 9:108.  https://doi.org/10.3389/fncel.2015.00108 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Papadopoulos MC, Krishna S, Verkman AS (2002) Aquaporin water channels and brain edema. Mt Sinai J Med 69(4):242–248PubMedGoogle Scholar
  5. 5.
    Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS (2000) Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6(2):159–163CrossRefPubMedGoogle Scholar
  6. 6.
    Stewart MJ, Malek K, Crabb DW (1996) Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J Investig Med 44(2):42–46PubMedGoogle Scholar
  7. 7.
    Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321(5895):1493–1495.  https://doi.org/10.1126/science.1158554 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Guo JM, Liu AJ, Zang P, Dong WZ, Ying L, Wang W, Xu P, Song XR, Cai J, Zhang SQ, Duan JL, Mehta JL, Su DF (2013) ALDH2 protects against stroke by clearing 4-HNE. Cell Res 23(7):915–930.  https://doi.org/10.1038/cr.2013.69 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, Tay WT, Chen CH, Zhang Y, Yamamoto K, Yamori Y, Nakashima E, Jaquish CE, Lee JY, Seielstad M, Isono M, Hixson JE, Chen YT, Miki T, Zhou X, Sugiyama T, Jeon JP, Liu JJ, Takayanagi R, Kim SS, Aung T, Sung YJ, Zhang X, Wong TY, Han BG, Kobayashi S, Ogihara T, Zhu D, Iwai N, Wu JY, Teo YY, Tai ES, Cho YS, He J (2011) Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 43(6):531–538.  https://doi.org/10.1038/ng.834 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Peng G-S, Yin S-J (2008) Effect of the allelic variants of aldehyde dehydrogenase ALDH2*2 and alcohol dehydrogenase ADH1B*2 on blood acetaldehyde concentrations. Hum Genomics 3(2):121–127CrossRefGoogle Scholar
  11. 11.
    Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84–91CrossRefPubMedGoogle Scholar
  12. 12.
    Garcia JH, Wagner S, Liu K-F, Hu X-j (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 26:627–634CrossRefPubMedGoogle Scholar
  13. 13.
    Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y (2010) Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res 209(1):119–122.  https://doi.org/10.1016/j.bbr.2010.01.026 CrossRefPubMedGoogle Scholar
  14. 14.
    Ikeda-Matsuo Y, Ota A, Fukada T, Uematsu S, Akira S, Sasaki Y (2006) Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc Natl Acad Sci USA 103(31):11790–11795.  https://doi.org/10.1073/pnas.0604400103 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3(6):1101–1108.  https://doi.org/10.1038/nprot.2008.73 CrossRefPubMedGoogle Scholar
  16. 16.
    Fu SH, Zhang HF, Yang ZB, Li TB, Liu B, Lou Z, Ma QL, Luo XJ, Peng J (2014) Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes. Naunyn-Schmiedeberg’s Arch Pharmacol 387(1):87–94.  https://doi.org/10.1007/s00210-013-0922-8 CrossRefGoogle Scholar
  17. 17.
    Yang H, Song Z, Yang GP, Zhang BK, Chen M, Wu T, Guo R (2014) The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels. PLoS ONE 9(10):e109634.  https://doi.org/10.1371/journal.pone.0109634 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Lu Z, Bourdi M, Li JH, Aponte AM, Chen Y, Lombard DB, Gucek M, Pohl LR, Sack MN (2011) SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Rep 12(8):840–846.  https://doi.org/10.1038/embor.2011.121 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Belmont-Diaz JA, Yoval-Sanchez B, Calleja-Castaneda LF, Pardo Vazquez JP, Rodriguez-Zavala JS (2016) Alda-1 modulates the kinetic properties of mitochondrial aldehyde dehydrogenase (ALDH2). FEBS J 283(19):3637–3650.  https://doi.org/10.1111/febs.13833 CrossRefPubMedGoogle Scholar
  20. 20.
    Stachowicz A, Glombik K, Olszanecki R, Basta-Kaim A, Suski M, Lason W, Korbut R (2016) The impact of mitochondrial aldehyde dehydrogenase (ALDH2) activation by Alda-1 on the behavioral and biochemical disturbances in animal model of depression. Brain Behav Immun 51:144–153.  https://doi.org/10.1016/j.bbi.2015.08.004 CrossRefPubMedGoogle Scholar
  21. 21.
    Wang W, Lin L-L, Guo J-M, Cheng Y-Q, Qian J, Mehta JL, Su D-F, Luan P, Liu A-J (2015) Heavy ethanol consumption aggravates the ischemic cerebral injury by inhibiting ALDH2. Int J Stroke 10(8):1261–1269.  https://doi.org/10.1111/ijs.12560 PubMedGoogle Scholar
  22. 22.
    Vaishnav RA, Singh IN, Miller DM, Hall ED (2010) Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. J Neurotrauma 27(7):1311–1320.  https://doi.org/10.1089/neu.2009.1172 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Poli G, Schaur RJ (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50(4–5):315–321.  https://doi.org/10.1080/713803726 CrossRefPubMedGoogle Scholar
  24. 24.
    Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari UM (2002) Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radical Biol Med 32(4):350–359CrossRefGoogle Scholar
  25. 25.
    Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, Awasthi S, Awasthi YC (2003) Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem 278(42):41380–41388.  https://doi.org/10.1074/jbc.M305766200 CrossRefPubMedGoogle Scholar
  26. 26.
    Qi LL, Fang SH, Shi WZ, Huang XQ, Zhang XY, Lu YB, Zhang WP, Wei EQ (2011) CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes. Life Sci 88(1–2):50–56.  https://doi.org/10.1016/j.lfs.2010.10.025 CrossRefPubMedGoogle Scholar
  27. 27.
    Arima H, Yamamoto N, Sobue K, Umenishi F, Tada T, Katsuya H et al (2003) Hyperosmolar mannitol stimulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase dependent pathway in rat astrocytes. J Biol Chem 278(45):44525–44534.  https://doi.org/10.1074/jbc.M304368200 CrossRefPubMedGoogle Scholar
  28. 28.
    Zador Z, Stiver S, Wang V, Manley GT (2009) Role of aquaporin-4 in cerebral edema and stroke. Handb Exp Pharmacol 190:150–170.  https://doi.org/10.1007/978-3-540-79885-9_7 Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.The Department of Anesthesiology, The Fourth Affiliated HospitalHarbin Medical UniversityHarbinChina

Personalised recommendations